68Ga-PSMA-11 PET/TC en la recidiva bioquímica oculta del carcinoma de próstata, con 18F-Colina PET/TC negativa. Valoración preliminar de su uso clínico-Reference-Cited by-同舟云学术

68Ga-PSMA-11 PET/TC en la recidiva bioquímica oculta del carcinoma de próstata, con 18F-Colina PET/TC negativa. Valoración preliminar de su uso clínico

Published:2021-06 Issue:5 Volume:45 Page:353-358
ISSN:0210-4806
Container-title:Actas Urológicas Españolas
language:es
Short-container-title:Actas Urológicas Españolas

Author:

Plaza López P.J.,Puertas E.,Aguiló J.J.,Suarez-Piñera M.,Domenech B.,Mestre-Fusco A.,Casals J.,Chicharo de Fleitas J.R.

Publisher

Elsevier BV

Subject

Urology

Reference15 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin.,2011

2. [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy;Giovacchini;Eur J Nucl Med Mol Imaging.,2008

3. 11C-Colina Bellaterra: Universitat Autònoma de Barcelona;Plaza López,2013

4. 18F-Choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/ml) after radical prostatectomy;Vees;BJU Int.,2007

5. Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results;Nanni;Eur J Nucl Med Mol Imaging.,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head-to-head comparison of prostate-specific membrane antigen positron emission tomography/computed tomography and multiparametric magnetic resonance imaging in the detection of biochemical recurrence of prostate cancer: a systematic review and meta-analysis;Clinical Radiology;2024-06

2. Current understanding of prostate cancer biomarkers;Cancer Urology;2024-02-27

3. Cost analysis of next-generation imaging in high-risk prostate cancer staging;Actas Urológicas Españolas (English Edition);2023-12

4. A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy;Annals of Nuclear Medicine;2023-11-06

5. Análisis de coste de pruebas de nueva generación en estadificación de pacientes con cáncer de próstata de alto riesgo;Actas Urológicas Españolas;2023-11